MiNA Therapeutics procures $30m Series A
MiNA Therapeutics, a provider of RNA activation therapeutics, has raised $30 million in Series A funding.
10 September 2020•3 mins read
MiNA Therapeutics, a provider of RNA activation therapeutics, has raised $30 million in Series A funding.